Mental health, stigma and risk perception among early adopters of HIV PrEP with LA Cabotegravir in Italy: a multicenter cross-sectional and implementation study
Objectives: Long-acting injectable cabotegravir (CAB-LA) offers an alternative to oral pre-exposure prophylaxis (PrEP), with potential benefits for adherence and stigma reduction. We investigated behavioral and psychosocial factors among early CAB-LA adopters in Italy, focusing on mental health, sti...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2026-02-01
|
| Серии: | International Journal of Infectious Diseases |
| Предметы: | |
| Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S1201971225004953 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
